anmelden
OMX Nordic 40
2.636,21
PKT
-39,11
PKT
-1,46
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.01.25 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 30.01.25 | Nokia Market-Perform | Bernstein Research | |
| 30.01.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 30.01.25 | Volvo (B) Neutral | UBS AG | |
| 30.01.25 | AstraZeneca Neutral | UBS AG | |
| 30.01.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 30.01.25 | Nokia Neutral | UBS AG | |
| 30.01.25 | Hennes Mauritz (H M, H&M) Buy | UBS AG | |
| 30.01.25 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | Nokia Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 30.01.25 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 29.01.25 | Novo Nordisk Buy | UBS AG | |
| 29.01.25 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 29.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.01.25 | Volvo (B) Neutral | UBS AG | |
| 29.01.25 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Deutsche Bank AG | |
| 29.01.25 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 29.01.25 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
| 28.01.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 28.01.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 28.01.25 | Novo Nordisk Buy | UBS AG | |
| 27.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.01.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 27.01.25 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 24.01.25 | Novo Nordisk Buy | UBS AG | |
| 24.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 24.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.01.25 | Ericsson (Telefon L.M.Ericsson) (B) Underweight | Barclays Capital | |
| 24.01.25 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 24.01.25 | Ericsson (Telefon L.M.Ericsson) (B) Sell | Goldman Sachs Group Inc. | |
| 24.01.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 24.01.25 | Ericsson (Telefon L.M.Ericsson) (B) Sell | UBS AG | |
| 24.01.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 23.01.25 | Volvo (B) Neutral | UBS AG | |
| 22.01.25 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 21.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 21.01.25 | Novo Nordisk Buy | UBS AG |